Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Moderna, Inc.

< Previous 1 2 3 4 5 6 Next >
News headline image
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345)
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Therapeutic
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Establishment of New Charitable Foundation
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Recipharm Site in France Manufacturing COVID-19 Vaccine Moderna Following Approval by European Medicines Agency
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Kate Cronin to Join Moderna as Chief Brand Officer on July 12
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Reaffirms Commitment to Job Creation in Massachusetts
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Dr. Paul Burton to Join Moderna as Chief Medical Officer
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
News headline image
Moderna to Present at Upcoming Investor Conferences in June 2021
From Moderna, Inc.
Via Business Wire
Tickers MRNA
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.